<DOC>
	<DOCNO>NCT00313807</DOCNO>
	<brief_summary>Exposure radiographic contrast dye coronary angiography well know cause either transient decrease renal function acute renal failure . Although overall incidence low , acute renal failure occur frequently patient diabetes chronic renal failure average report incidence upwards 20 % . The etiology contrast-induced nephropathy relate acute decline renal blood flow follow dye exposure result ischemic injury level medulla . The development acute renal failure follow radiocontrast dye administration significant contribute morbidity mortality patient risk . The administration amino acid , either intravenous infusion protein meal , result substantial increase renal plasma flow ( RPF ) glomerular filtration rate ( GFR ) . In healthy subject chronic renal failure , amino acid infusion produce 20 % rise GFR effective RPF . We hypothesize 20 % rise effective RPF GFR follow amino acid infusion counteract radiocontrast dye-induced vasoconstriction reduce renal toxicity contrast medium group high-risk patient .</brief_summary>
	<brief_title>Study Intravenous Amino Acid Infusion Prevent Contrast Dye Mediated Renal Damage</brief_title>
	<detailed_description>Exposure radiographic contrast dye coronary angiography well know cause either transient decrease renal function acute renal failure . Retrospective study confirm least 60 % contrast-associated nephropathy occur subject chronic renal failure . The incidence approach 20 % baseline creatinine great 198.2 μmol per liter ( 2.25 mg/dL ) . Diabetes , absence renal insufficiency , appear confer added risk ; however diabetic patient chronic renal failure high risk . It particularly group develop oliguric renal failure require temporary permanent renal replacement therapy . In diabetic patient mild moderate renal failure , incidence contrast-associated nephropathy report 9 % 40 % however great 50 % incidence note diabetic patient severely impaired renal function . It hypothesize renal toxicity contrast medium related local vasoconstriction . We hypothesize protein-stimulated rise effective RPF GFR might counteract intrarenal vasoconstriction reduce toxicity contrast medium high-risk patient diabetes . We propose infusion amino acid prior administration contrast dye , increase renal plasma flow glomerular filtration rate approximately 20 % hasten excretion contrast agent thereby protect high-risk patient contrast nephropathy . This double-blind , randomize , placebo-controlled trial evaluate effectiveness amino-acid infusion addition usual therapy ( intravenous normal saline infusion ) prevention renal dysfunction follow angiographic dye administration coronary angiography high risk group patient chronic renal insufficiency . Comparison : Primary secondary outcome patient receive intravenous amino acid infusion compare placebo group receive intravenous normal saline .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Greater 18 year age Referral coronary angiography Type 1 type 2 diabetic require insulin oral hypoglycemic agent Stable serum creatinine concentration ( 140 300 μmol per liter men 125 300 μmol per liter woman creatinine clearance great 60 ml/min ( calculate CockcroftGault equation ) Non diabetic subject stable serum creatinine concentration 160 300 µmol per liter men 140 300 µmol per liter woman . Stable renal function define documented rise fall serum creatinine 44 umol/L precede 2 week Refusal inability give consent Pregnant Nonelective coronary angiography Recent administration ( within 21 day ) iodinate intravenous contrast dye Recent administration ( within 21 day ) nonsteroidal antiinflammatory drug ( exclude aspirin ) , aminoglycoside antibiotic chemotherapeutic agent Severe/unstable diabetic require emergency room inpatient therapy previous 21 day Compensated decompensated hepatic failure Renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>contrast nephropathy</keyword>
	<keyword>renal failure</keyword>
	<keyword>Travasol</keyword>
</DOC>